Site Expansion
June 08, 2022
Leadership
February 02, 2022
RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture
Cell Therapy, Investment, Partnerships
January 11, 2022
GHO Capital invests in RoslinCT, a leading cell therapy CDMO
![[Q&A] Navigating Cell Therapy Supply Chain Challenges](https://www.roslinct.com/wp-content/uploads/2023/05/Blog-407x271-8.jpg.webp)
![[EBOOK] Build Vs. Buy: A Critical Calculation for Cell Therapy Innovators](https://www.roslinct.com/wp-content/uploads/2021/12/Blog-407x271-6.jpg.webp)
Cell Therapy, eBook
December 02, 2021
[EBOOK] Build Vs. Buy: A Critical Calculation for Cell Therapy Innovators
